Kenvue Inc.
Kenvue Inc. is a consumer health company built around everyday self-care, skin health, and essential health products sold under brands such as Tylenol, Listerine, Neutrogena, BAND-AID, Aveeno, Johnson’s, Nicorette, and Zyrtec. The company combines consumer marketing, scientific claims, and healthcare-professional trust to sell over-the-counter medicines, oral care, skin care, and personal care products in more than 165 countries.
Fiscal year 2025 · change from previous year
Development 2022–2025
Business
Share of revenueIncludes OTC medicines and consumer health products for pain, allergy, cough/cold, and smoking cessation.
Includes facial care, body care, and dermatologist-recommended skin brands such as Neutrogena and Aveeno.
Includes oral care, baby care, and wound care products used in daily routines and basic household care.
Customers
Kenvue sells primarily through retail and consumer health channels to households that buy trusted, repeat-use products for everyday care. Its customers also include large-format retailers, pharmacy chains, and e-commerce platforms that use bargaining power to negotiate pricing, trade support, and promotional terms. Demand is driven by brand trust, scientific credibility, and convenience rather than complex installation or service requirements.
Buy Tylenol, Listerine, Neutrogena, and other staples for broad consumer resale and shelf traffic.
Purchase everyday care products for pain relief, oral care, skin care, baby care, and first aid.
Buy through online marketplaces and direct digital channels where search, reviews, and convenience matter.
Choose products such as Nicorette, Zyrtec, and Tylenol based on efficacy and professional recommendation.
Strategy
Kenvue is focused on transforming into a more efficient, digitally enabled consumer health company while improving execution and profitability. Management is using restructuring, shared services, and supply-chain optimization to fund brand investment, strengthen commercial capabilities, and support sustainable growth. In July 2025, the board also launched a strategic review of alternatives, including portfolio optimization, to unlock value.
Lower overhead and improve margins so more cash can be reinvested in brands and capabilities.
Better consumer targeting and e-commerce execution are needed in a more fragmented retail environment.
Portfolio optimization may improve growth quality and unlock value across brands and categories.
Geography
2025Kenvue operates globally across North America, APAC, EMEA, and LATAM, with products marketed in more than 165 countries. The company’s manufacturing and supply chain are described as globally balanced and purpose-built to shift resources across regions, which helps it manage retailer demand swings, shipping timing, and local consumer trends. China is specifically called out in the reports as a market where changing shopping patterns and consumer sentiment have affected performance in skin health.
Share of the revenue the company reports by geography.
Risks
Kenvue faces pressure from powerful retailers, changing consumer preferences, and intense competition from CPG, pharma, private label, and niche brands. Its transformation also creates execution risk through restructuring, IT modernization, cybersecurity exposure, and dependence on third parties for manufacturing and supply. In addition, product quality, regulatory compliance, and litigation remain important because the company sells health-related products with consumer safety implications.
- Retail concentration and bargaining pressureImpact: HighLikelihood: Medium
Large customers and buying alliances can demand more trade promotions, media support, and discounts, reducing profitability.
Exposure: U.S. and global retail channels
- Consumer preference and demand volatilityImpact: HighLikelihood: Medium
The company depends on fast response to changing shopping patterns, seasonality, and regional trends.
Exposure - Supply chain and third-party manufacturing dependenceImpact: HighLikelihood: Medium
Kenvue relies on external partners and a global network, which reduces direct control over quality and continuity.
Exposure: Global sourcing and manufacturing
- Cybersecurity and technology systems disruptionImpact: HighLikelihood: Medium
Digital strategy and third-party integrations increase exposure to breaches, outages, and data misuse.
Exposure - Regulatory, litigation, and product safety exposureImpact: HighLikelihood: Medium
Consumer health products face FDA oversight, compliance scrutiny, and potential claims tied to safety or labeling.
Exposure: OTC medicines and personal care products
Accounting
Judgemental itemsTrade promotions, rebates, discounts, and returns are estimated at sale and reduce net sales.
Impact: Can shift reported revenue and gross margin when estimates change
Allergy, cough/cold, and pediatric pain categories can fluctuate materially by quarter.
Impact: Affects comparability of quarterly sales and inventory levels
Brand and asset values depend on forecasts and market assumptions, as shown by Dr.Ci:Labo charges.
Impact: Can create large non-cash charges and signal weaker category outlook
Our Vue Forward and related initiatives generate workforce, IT, and project costs.
Impact: Impacts operating expenses and near-term earnings
The company operates globally and faces ordinary-course legal and regulatory matters.
Impact: Can affect tax expense, reserves, and cash flows
Similar listed companies
Publicly listed companies with a comparable business focus.
PERRIGO Co plc
PRGO · Pharmaceutical Preparations
Perrigo Co plc is a consumer self-care company focused on over-the-counter health and wellness products sold through retail and pharmacy channels.
Prestige Consumer Healthcare Inc.
PBH · Pharmaceutical Preparations
ENvue Medical, Inc.
FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Kun Peng International Ltd.
KPEA · Services-Educational Services
Haleon plc
HLN · Perfumes, Cosmetics & Other Toilet Preparations
Haleon plc is a consumer health company focused on everyday self-care and over-the-counter wellness products.
Longduoduo Co Ltd
LDDD · Services-Health Services
Longduoduo Co Ltd is a U.S.-listed company with operating subsidiaries in Inner Mongolia and Beijing that generates revenue from two main activities: direct…
Last updated: 24/09/2026